Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-22
1997-09-30
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544370, A61K 31495, C07D40304
Patent
active
056726040
ABSTRACT:
New 1-phenylmethyl enzimidazole piperazine derivatives of general formula ##STR1## are described wherein R.sup.1 and R.sup.2 can be a hydrogen atom, a halogen atom, a short chain alkyl group, a nitro group, and a hydroxy group, and their addition salts with pharmaceutically acceptable acids.
These compounds have pharmacological activity as serotonin 5HT.sub.3 receptor antagonists.
REFERENCES:
patent: 5106857 (1992-04-01), Cale, Jr. et al.
patent: 5256665 (1993-10-01), Orjales-Venero et al.
Iemura et al, Chem. Pharm. Bull, 37(10), pp. 2723-2726 (1989).
Iemura et al, Chem. Pharm. Bull. 37 (4) pp. 967-972 (1989).
Kodama et al., Chemical Abstracts, vol.84, No.44060 (1976) (Abs. for JP 126682, Oct. 4, 1975).
Hasegawa et al., Chemical Abstracts, vol.82, No.156308 (19).
Orjales-Venero Aurelio
Rodes-Solanes Rosa
Bernhardt Emily
Fabrica Espanola de Productos Quimicos y Farmaceuticos (FAES)
LandOfFree
1-phenylmethyl benzimidazole piperazine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-phenylmethyl benzimidazole piperazine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-phenylmethyl benzimidazole piperazine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2256793